Investors / filer profile

Mirza Mansoor Raza

Chief Medical Officer

active in 2 companies

Pro
Bought: Pro
Sold: 9
Filings: 2
Companies: 2026-05-18
Last filed

EDGAR · CIK 0001588389 ↗

Track record

How each disclosed position did against the S&P ~6 months later

No positions we can measure against the market yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$0.0000 bought · −$4.3K sold

All filings on record

Every Form 4 transaction we track for this filer


ACRVAcrivon Therapeutics, Inc.	Grant — · 38,817 sh	2026-05-18	—
SERASERA PROGNOSTICS, INC.	Sell $890.60 · 292 sh	2025-12-05	—
SERASERA PROGNOSTICS, INC.	Sell $671.84 · 221 sh	2025-11-05	—
SERASERA PROGNOSTICS, INC.	Sell $717.32 · 227 sh	2025-10-06	—
SERASERA PROGNOSTICS, INC.	Sell $743.70 · 222 sh	2025-09-05	—
SERASERA PROGNOSTICS, INC.	Sell $562.50 · 225 sh	2025-08-05	—
SERASERA PROGNOSTICS, INC.	Sell $552.24 · 234 sh	2025-07-07	—
SERASERA PROGNOSTICS, INC.	Sell $169.06 · 107 sh	2025-06-06	—
SERASERA PROGNOSTICS, INC.	Grant — · 15,596 sh	2025-06-05	—

ACRVGrant

2026-05-18 · Acrivon Therapeutics, Inc.

38,817

—

SERASell

2025-12-05 · SERA PROGNOSTICS, INC.

$890.60

—

SERASell

2025-11-05 · SERA PROGNOSTICS, INC.

$671.84

—

SERASell

2025-10-06 · SERA PROGNOSTICS, INC.

$717.32

—

SERASell

2025-09-05 · SERA PROGNOSTICS, INC.

$743.70

—

SERASell

2025-08-05 · SERA PROGNOSTICS, INC.

$562.50

—

SERASell

2025-07-07 · SERA PROGNOSTICS, INC.

$552.24

—

SERASell

2025-06-06 · SERA PROGNOSTICS, INC.

$169.06

—

SERAGrant

2025-06-05 · SERA PROGNOSTICS, INC.

15,596

—

9 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.